Director
Translational Immunology Institute, SingHealth, Singapore
Salvatore Albani, M.D., PhD, - Professor of Medicine at Duke-NUS Medical School in Singapore, and the Director of the Translational Immunology Institute at SingHealth-Duke-NUS AMC. Before joining Duke-NUS, Dr. Albani served as director of the Translational Medicine Unit at the Clinical Investigation Institute at the University of California, San Diego, where he also was professor of Medicine and Pediatrics. His fundamental research interest is in understanding human immunity and contributing the knowledge to therapeutic and diagnostic advancements. He has developed several innovative approaches in the area of induction and maintenance of immune tolerance in humans, being responsible for the whole translational process from idea to the conclusion of a Phase II clinical trial in autoimmune inflammatory diseases. He has been responsible for conception and execution of each of the stages of this complex itinerary, which spans a wide and diverse gradient of technologies and challenges. These include molecular immunology, lead identification and validation, intellectual property, CMC, IND, trial design, data management and analysis, interfacing with VC and Pharma, leading complex groups in a multi-center setting. This translational research itinerary has been the original backbone of his career, as witnessed by a rich publication trail. Development of high throughput technology platforms is also part of his scientific career. These platforms aim to provide tools for knowledge-based diagnostic and therapeutic decisions. In his role as an educator, it has been his privilege to mentor many talented individuals, and to provide the right challenges and learning opportunities to help them grow and advance.
